Trump ad­min­is­tra­tion preps ex­ec­u­tive or­der on price trans­paren­cy as law­mak­ers con­verge — WSJ

In a po­lit­i­cal sphere where Re­pub­li­cans and De­moc­rats can find lit­tle com­mon ground, the phar­ma in­dus­try in gen­er­al — and price trans­paren­cy in par­tic­u­lar — has pre­sent­ed …

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER